Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Iman El-Hariry
Age : 59
Linked companies : ERYTECH Pharma S.A.
Summary 
Iman El-Hariry is Chief Medical Officer at ERYTech Pharma SA and Chief Medical Officer for Erytech, Inc. (a subsidiary of ERYTech Pharma SA).

She previously occupied the position of President at Azure Oncology Consulting LLC, Global Head-Oncology at Astellas Pharma, Inc., Vice President-Clinical Research at Synta Pharmaceuticals Corp. and Director-Clinical Development at Glaxo Smith Kline Biologicals NA.

Dr. El-Hariry received a doctorate from Imperial College London and a doctorate from Alexandria Faculty of Medicine.


Current positions of Iman El-Hariry 
NameTitle Since
ERYTECH Pharma S.A.
(Biotechnology & Medical Research)
Chief Medical Officer -
Erytech, Inc. Chief Medical Officer 2015


Holdings of Iman El-Hariry 
NameEquities%Valuation
ERYTECH Pharma S.A. (ERYP)
(Biotechnology & Medical Research)
00.0000%0 USD


Iman El-Hariry: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Iman El-Hariry : Connections